These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28781990)

  • 1. The Microphysiology Systems Database for Analyzing and Modeling Compound Interactions with Human and Animal Organ Models.
    Gough A; Vernetti L; Bergenthal L; Shun TY; Taylor DL
    Appl In Vitro Toxicol; 2016 Jun; 2(2):103-117. PubMed ID: 28781990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of the microphysiology systems database for experimental ADME-Tox and disease models.
    Schurdak M; Vernetti L; Bergenthal L; Wolter QK; Shun TY; Karcher S; Taylor DL; Gough A
    Lab Chip; 2020 Apr; 20(8):1472-1492. PubMed ID: 32211684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human liver microphysiology platform for investigating physiology, drug safety, and disease models.
    Vernetti LA; Senutovitch N; Boltz R; DeBiasio R; Shun TY; Gough A; Taylor DL
    Exp Biol Med (Maywood); 2016 Jan; 241(1):101-14. PubMed ID: 26202373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical Considerations for the Design of Multi-Organ Microphysiological Systems (MPS).
    Malik M; Yang Y; Fathi P; Mahler GJ; Esch MB
    Front Cell Dev Biol; 2021; 9():721338. PubMed ID: 34568333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Combination of a Human Biomimetic Liver Microphysiology System with BIOLOGXsym, a Quantitative Systems Toxicology (QST) Modeling Platform for Macromolecules, Provides Mechanistic Understanding of Tocilizumab- and GGF2-Induced Liver Injury.
    Beaudoin JJ; Clemens L; Miedel MT; Gough A; Zaidi F; Ramamoorthy P; Wong KE; Sarangarajan R; Battista C; Shoda LKM; Siler SQ; Taylor DL; Howell BA; Vernetti LA; Yang K
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Coupling of Human Microphysiology Systems: Intestine, Liver, Kidney Proximal Tubule, Blood-Brain Barrier and Skeletal Muscle.
    Vernetti L; Gough A; Baetz N; Blutt S; Broughman JR; Brown JA; Foulke-Abel J; Hasan N; In J; Kelly E; Kovbasnjuk O; Repper J; Senutovitch N; Stabb J; Yeung C; Zachos NC; Donowitz M; Estes M; Himmelfarb J; Truskey G; Wikswo JP; Taylor DL
    Sci Rep; 2017 Feb; 7():42296. PubMed ID: 28176881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of rat or human hepatocytes cultured in microphysiological systems (MPS) to identify hepatotoxicity.
    Chang SY; Voellinger JL; Van Ness KP; Chapron B; Shaffer RM; Neumann T; White CC; Kavanagh TJ; Kelly EJ; Eaton DL
    Toxicol In Vitro; 2017 Apr; 40():170-183. PubMed ID: 28089783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-functional scaling methodology for translational pharmacokinetic and pharmacodynamic applications using integrated microphysiological systems (MPS).
    Maass C; Stokes CL; Griffith LG; Cirit M
    Integr Biol (Camb); 2017 Apr; 9(4):290-302. PubMed ID: 28267162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editor's Highlight: An Impaired Immune Tolerance Animal Model Distinguishes the Potential of Troglitazone/Pioglitazone and Tolcapone/Entacapone to Cause IDILI.
    Mak A; Kato R; Weston K; Hayes A; Uetrecht J
    Toxicol Sci; 2018 Feb; 161(2):412-420. PubMed ID: 29087505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing Human Microphysiology Systems as Key Experimental Models for Quantitative Systems Pharmacology.
    Taylor DL; Gough A; Schurdak ME; Vernetti L; Chennubhotla CS; Lefever D; Pei F; Faeder JR; Lezon TR; Stern AM; Bahar I
    Handb Exp Pharmacol; 2019; 260():327-367. PubMed ID: 31201557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microfluidic Cell Culture Platforms to Capture Hepatic Physiology and Complex Cellular Interactions.
    Bale SS; Borenstein JT
    Drug Metab Dispos; 2018 Nov; 46(11):1638-1646. PubMed ID: 30115643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A thermoplastic microfluidic microphysiological system to recapitulate hepatic function and multicellular interactions.
    Bale SS; Manoppo A; Thompson R; Markoski A; Coppeta J; Cain B; Haroutunian N; Newlin V; Spencer A; Azizgolshani H; Lu M; Gosset J; Keegan P; Charest JL
    Biotechnol Bioeng; 2019 Dec; 116(12):3409-3420. PubMed ID: 30963546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
    Watson DE; Hunziker R; Wikswo JP
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing quasi-steady state operations of microphysiological systems (MPS) using tissue-specific metabolic dependencies.
    Maass C; Dallas M; LaBarge ME; Shockley M; Valdez J; Geishecker E; Stokes CL; Griffith LG; Cirit M
    Sci Rep; 2018 May; 8(1):8015. PubMed ID: 29789564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
    Amacher DE
    Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the inhibitory effects of tolcapone and entacapone against human UDP-glucuronosyltransferases.
    Lv X; Wang XX; Hou J; Fang ZZ; Wu JJ; Cao YF; Liu SW; Ge GB; Yang L
    Toxicol Appl Pharmacol; 2016 Jun; 301():42-9. PubMed ID: 27089846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Systems Pharmacology Approaches Applied to Microphysiological Systems (MPS): Data Interpretation and Multi-MPS Integration.
    Yu J; Cilfone NA; Large EM; Sarkar U; Wishnok JS; Tannenbaum SR; Hughes DJ; Lauffenburger DA; Griffith LG; Stokes CL; Cirit M
    CPT Pharmacometrics Syst Pharmacol; 2015 Oct; 4(10):585-94. PubMed ID: 26535159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capture compound mass spectrometry sheds light on the molecular mechanisms of liver toxicity of two Parkinson drugs.
    Fischer JJ; Michaelis S; Schrey AK; Graebner OG; Glinski M; Dreger M; Kroll F; Koester H
    Toxicol Sci; 2010 Jan; 113(1):243-53. PubMed ID: 19783845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicology and safety of COMT inhibitors.
    Haasio K
    Int Rev Neurobiol; 2010; 95():163-89. PubMed ID: 21095462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
    Singh SS
    Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.